Radiation therapy induces the p53(+)p21(-) expression in squamous cell carcinomas of the uterine cervix

Gynecologic Oncology

Volumn 93, Issue 2, 2004, Pages 340-344

  Oka, Kuniyuki ^a,c,d   Suzuki, Yoshiyuki ^b,c   Iida, Hiroko ^c   Nakano, Takashi ^b,c  

^a Mito Saiseikai General Hospital   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^d MITO SAISEIKAI GENERAL HOSPITAL   (Japan)

Author keywords

A radiation dose of 27 Gy; Cervical squamous cell carcinoma; p21; p53; Radiation therapy effect

Indexed keywords

PROTEIN P21; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL DEGENERATION; CELL SWELLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; STAINING; SURVIVAL RATE; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; HUMANS; MIDDLE AGED; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 1942476925     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.02.009     Document Type: Article

References (24)

1. Fei P., El-Deiry W.S. P53 and radiation responses. Oncogene. 22:2003;5774-5783.
2. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
3. Harper J.W., Adami G.R., Wei N., Keyomarski K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
4. Michieli P., Chedid M., Lin D., Pierce J.H., Mercer W.E., Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:1994;3391-3395.
5. Arai T., Nakano T., Morita S., Sakashita K., Nakamura Y.K., Fukuhisa K. High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. A 20-year experience. Cancer. 69:1992;175-180.
6. Shi S.-R., Key M.E., Kalra K. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 1991;741-748.
7. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
8. Reihsaus E., Kohler M., Kraiss S., Oren M., Montenarch M. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells. Oncogene. 5:1990;137-145.
9. Iggo R., Gatter K., Bartek J., Lane D., Harris A.L. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet. 335:1990;675-679.
10. Rodrigues N.R., Rowan A., Smith M.E.F., Kerr I.B., Bodmer W.F., Gannon J.V.et al. p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. U. S. A. 87:1990;7555-7559.
11. Ku W.H., Liu I.L., Yen M.S., Chang Chien C.C., Yue C.T., Ma Y.Y.et al. Genomic deletion and p53 inactivation in cervical carcinoma. Int. J. Cancer. 72:1997;270-276.
12. Helland, Holm R., Kristensen G., Kaern J., Karlsen F., Trope C.et al. Genetic alterations of the p53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. J. Pathol. 171:1993;105-114.
13. Pillai M.R., Jayaprakash P.G., Nair M.K. bcl-2 immunoreactivity but not p53 accumulation associated with tumour response to radiotherapy in cervical carcinoma. J. Cancer Res. Clin. Oncol. 125:1999;55-60.
14. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:1994;4855-4878.
15. Riou G., Favre M., Jeannel D., Bourhis J., Doussal V.L., Orth G. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet. 335:1990;1171-1174.
16. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as an ubiquitin-protein ligase in the ubiquitination of p53. Cell. 75:1993;495-505.
17. Huibregtse J.M., Scheffner M., Howley P.M. Cloning and expression of the cDNA for E6AP, a protein that mediates the interaction of the human papilloma virus E6 oncoprotein with p53. Mol. Cell. Biol. 13:1993;775-784.
18. Ishikawa H., Mitsuhashi N., Sakurai H., Maebayashi K., Niibe H. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone. Cancer. 91:2001;80-89.
19. Seta T., Imazeki F., Yokosuka O., Saisho H., Suzuki T., Koide Y.et al. Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers. Comparison with mutations of thep53 gene. Dig. Dis. Sci. 43:1998;279-289.
20. Fu C.G., Tominaga O., Nagawa H., Nita M.E., Masaki T., Ishimaru G.et al. Role of p53 and p21/WAF1 detection in patient selection for pre operative radiotherapy in rectal cancer patients. Dis. Colon Rectum. 41:1998;68-74.
21. Tatemoto Y., Osaki T., Yoneda K., Yamamoto T., Ueta E., Kimura T. Expression of p53 and p21 proteins in oral squamous cell carcinoma: correlation with lymph node metastasis and response to chemotherapy. Pathol. Res. Pract. 194:1998;821-830.
22. Pindzola J.A., Palazzo J.P., Kovatich A.J., Tuma B., Nobel M. Expression of p21WAF1/CIP1 in soft tissue sarcomas: a comparative immunohistochemical study with p53 and Ki-67. Pathol. Res. Pract. 194:1998;685-691.
23. Oka K., Suzuki Y., Nakano T. Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone. Cancer. 88:2000;2766-2773.
24. Ljung G., Egevad L., Norberg M., Holmberg L., Nilsson S., Busch C. Expression of p21 and mutant p53 gene products in residual prostatic tumor cells after radical radiotherapy. Prostate. 32:1997;99-105.